Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

PURPOSE: Triple-negative breast cancer (TNBC) is considered aggressive, and therefore, virtually all young patients with TNBC receive (neo)adjuvant chemotherapy. Increased stromal tumor-infiltrating lymphocytes (sTILs) have been associated with a favorable prognosis in TNBC. However, whether this as...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Vincent M.T., Wang, Yuwei, ter Hoeve, Natalie D., Opdam, Mark, Stathonikos, Nikolas, Jóźwiak, Katarzyna, Hauptmann, Michael, Cornelissen, Sten, Vreuls, Willem, Rosenberg, Efraim H., Koop, Esther A., Varga, Zsuzsanna, van Deurzen, Carolien H.M., Mooyaart, Antien L., Córdoba, Alicia, Groen, Emma J., Bart, Joost, Willems, Stefan M., Zolota, Vasiliki, Wesseling, Jelle, Sapino, Anna, Chmielik, Ewa, Ryska, Ales, Broeks, Annegien, Voogd, Adri C., Loi, Sherene, Michiels, Stefan, Sonke, Gabe S., van der Wall, Elsken, Siesling, Sabine, van Diest, Paul J., Schmidt, Marjanka K., Kok, Marleen, Dackus, Gwen M.H.E., Salgado, Roberto, Linn, Sabine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287283/
https://www.ncbi.nlm.nih.gov/pubmed/35353548
http://dx.doi.org/10.1200/JCO.21.01536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287283/
https://www.ncbi.nlm.nih.gov/pubmed/35353548
http://dx.doi.org/10.1200/JCO.21.01536

Ejemplares similares